phenol has been researched along with Pelvic Pain in 5 studies
Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.
Excerpt | Relevance | Reference |
---|---|---|
"To achieve this objective in a prospective observational study of 1 year follow-up; we performed laparoscopic presacral chemical neurolysis with phenol in 15 patients with pelvic pain and minimal-moderate endometriosis." | 3.72 | Laparoscopic presacral neurolysis for endometriosis-related pelvic pain. ( Gurses, E; Ozer, S; Soysal, ME; Soysal, S, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abdelghaffar, NA | 1 |
Farahat, TE | 1 |
Pollitt, CI | 1 |
Salota, V | 1 |
Leschinskiy, D | 1 |
Soysal, ME | 1 |
Soysal, S | 1 |
Gurses, E | 1 |
Ozer, S | 1 |
Turker, G | 1 |
Basagan-Mogol, E | 1 |
Gurbet, A | 1 |
Ozturk, C | 1 |
Uckunkaya, N | 1 |
Sahin, S | 1 |
Toshniwal, GR | 1 |
Dureja, GP | 1 |
Prashanth, SM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management: A Randomized Controlled Trial of Efficacy and Safety[NCT05427058] | 36 participants (Anticipated) | Interventional | 2022-08-01 | Not yet recruiting | |||
The Efficacy of Superior Hypogastric Blockade for Postoperative Pain[NCT03428152] | 78 participants (Actual) | Observational [Patient Registry] | 2018-02-09 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
the time from the the first incision to the skin to skin closure. (NCT03428152)
Timeframe: from the induction of anesthesia and the end of the surgery
Intervention | minutes (Mean) |
---|---|
Hypo | 115.83 |
NoHypo | 114.16 |
length of hospital stay time will be recorded (NCT03428152)
Timeframe: assessed up to 1 week
Intervention | days (Mean) |
---|---|
Hypo | 2.66 |
NoHypo | 2.96 |
Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward) (NCT03428152)
Timeframe: 48 hours (time to the first analgesic demand will be recorded)
Intervention | minutes (Mean) |
---|---|
Hypo | 627 |
NoHypo | 203.83 |
intra/postoperative complications will be noted. (post-operative nausea and vomiting (PONV) or others: ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. ) (NCT03428152)
Timeframe: From the SHP block time (intraoperative) until discharge
Intervention | Participants (Count of Participants) | |
---|---|---|
PONV | others | |
Hypo | 7 | 0 |
NoHypo | 8 | 0 |
"Total number of non-steroid anti-inflammatory drug (NSAID) and opioid vials that are applied to patients in post-anesthesia care unit (PACU) and at ward will be recorded.~Target VAS score for NSAID is >4; if there is no response to NSAID and pain is worsening opioid drugs will be applied (this is our routine clinical practice) NSAID: Diclofenac sodium 75mg per vial; opioid: Tramadol 100mg per vial." (NCT03428152)
Timeframe: postoperative 48 hour follow-up (PACU and ward)
Intervention | vials (Mean) | |||
---|---|---|---|---|
NSAID PACU | Opioid PACU | NSAID ward | Opioid ward | |
Hypo | 0.8 | 0.1 | 2.83 | 0 |
NoHypo | 0.96 | 0.36 | 5.77 | 0.63 |
Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever) (PACU: Post-anesthesia care unit) VAS-PACU: VAS scores at PACU VAS 1: VAS scores at postoperative 1st hour (ward) VAS 6: VAS scores at postoperative 6th hour (ward) VAS 12: VAS scores at postoperative 12th hour (ward) VAS 24: VAS scores at postoperative 24th hour (ward) VAS 48: VAS scores at postoperative 48th hour (ward) (NCT03428152)
Timeframe: postoperative 48 hour follow-up (PACU and ward)
Intervention | units on a scale (Mean) | |||||
---|---|---|---|---|---|---|
VAS PACU | VAS 1 | VAS 6 | VAS 12 | VAS 24 | VAS 48 | |
Hypo | 4.76 | 3.7 | 1.9 | 0.83 | 0.53 | 0.2 |
NoHypo | 7.38 | 6.66 | 4.23 | 3.16 | 2.1 | 1.2 |
2 trials available for phenol and Pelvic Pain
Article | Year |
---|---|
Fluoroscopic anterior approach versus ultrasound guided superior hypogastric plexus neurolysis in cancer pelvic pain: a randomized controlled study.
Topics: Bupivacaine; Cancer Pain; Fluoroscopy; Humans; Hypogastric Plexus; Neoplasms; Nerve Block; Pelvic Pa | 2022 |
Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study.
Topics: Anesthetics, Local; Anti-Inflammatory Agents; Autonomic Nerve Block; Bupivacaine; Female; Ganglia, S | 2007 |
3 other studies available for phenol and Pelvic Pain
Article | Year |
---|---|
Chemical neurolysis of the superior hypogastric plexus for chronic non-cancer pelvic pain.
Topics: Chronic Disease; Endometriosis; Female; Humans; Hypogastric Plexus; Nerve Block; Pelvic Pain; Phenol | 2011 |
Laparoscopic presacral neurolysis for endometriosis-related pelvic pain.
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Coitus; Constipation; Endometriosis; Fea | 2003 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |